Market Capitalization (Millions $) |
22,716 |
Shares
Outstanding (Millions) |
1,570 |
Employees |
- |
Revenues (TTM) (Millions $) |
27,902 |
Net Income (TTM) (Millions $) |
2,196 |
Cash Flow (TTM) (Millions $) |
5,887 |
Capital Exp. (TTM) (Millions $) |
974 |
Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited is a renowned global pharmaceutical company headquartered in Tokyo, Japan. Founded in 1781, it has a rich history of more than 230 years in the healthcare industry. Takeda operates with a mission to provide better health and brighter future for people worldwide through innovative and high-quality pharmaceutical products.
The company specializes in various therapeutic areas including oncology, gastroenterology, neuroscience, rare diseases, and vaccines. Takeda focuses on research and development (R&D) to discover and develop innovative medicines that address unmet medical needs and improve patient outcomes. They have a strong pipeline of promising drug candidates under development.
Takeda has a significant global presence, with operations in around 80 countries and regions. They collaborate with partners, healthcare professionals, and patient communities to deliver their products to patients in need across the globe. The company maintains a strong commitment to diversity and inclusion, environmental sustainability, and corporate social responsibility.
With a workforce of over 50,000 employees, Takeda continues to play a vital role in the pharmaceutical industry, constantly striving to improve healthcare and contribute to the well-being of people worldwide.
Company Address: 1-1, Nihonbashi-Honcho 2-Chome Tokyo 103
Company Phone Number: 3 3278-2306 Stock Exchange / Ticker: NYSE TAK
TAK is expected to report next financial results on June 27, 2024. |
|
|